Acadia Pharmaceuticals
Jennifer Fiorenza has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as Executive Director of Quality Risk & Compliance and Executive Director of Quality Management Operations at Acadia Pharmaceuticals Inc. since November 2021. Prior to this role, Fiorenza was Senior Director of Global Medical Affairs Strategic Operations at Novocure and held various leadership positions in Quality Management Operations at ACADIA Pharmaceuticals. Additional experience includes senior roles at Teva Pharmaceuticals and Shire, focusing on R&D quality, compliance, and training. Fiorenza's career began at Accenture as a Training & Human Performance Consultant, following a background in commercial credit analysis at Commerce Bank. Jennifer holds a Bachelor of Science in Finance and Business Law from Penn State University.
This person is not in any teams
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.